Connor, Clark & Lunn Investment Management (CC&L)’s American Renal Associates Holdings, Inc ARA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ARA Stock Details ARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-13,375	Closed	-$82K	–	1113
2019 Q1	$82K	Sell	13,375 -20,525	-61%	-$238K	﹤0.01%	879
2018 Q4	$391K	Buy	33,900 +5,925	+21%	+$101K	﹤0.01%	754
2018 Q3	$606K	Buy	+27,975	New	+$529K	﹤0.01%	658
2018 Q1	–	Sell	-16,325	Closed	-$284K	–	842
2017 Q4	$284K	Buy	+16,325	New	+$225K	﹤0.01%	689

Other funds holding ARA

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WIC

Whitegate Investment Counselors Concord, New Hampshire $351M AUM 16.12% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ARA Position: Q2 2019 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of American Renal Associates Holdings, Inc (ARA) in Q2 2019, closing a stake of 13,375 shares — an estimated $82K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ARA in Q4 2017 and held it in 4 quarters. The position peaked at $606K in Q3 2018. 67 funds tracked by Wall St. Rank hold ARA as of Q2 2019.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining American Renal Associates Holdings, Inc position as of Q2 2019 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 13,375 American Renal Associates Holdings, Inc shares in Q2 2019, an estimated $82K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in American Renal Associates Holdings, Inc in Q4 2017 and held it in 4 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s American Renal Associates Holdings, Inc position peaked at $606K in Q3 2018.
67 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q2 2019.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2019, filed 7 Aug 2019.